Megestrol Acetate: all 65 studies that test it

Page 1 of 1. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and ImmunotherapyNot yet recruitingNCT07565415Phase 2
• Megestrol Acetate for Fatigue Management in T-DXd Treated Breast CancerRecruitingNCT07543536Phase 3
• Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular CarcinomaNot yet recruitingNCT07356037Phase 3
• Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular ClassificationRecruitingNCT07319429Phase 2/3
• A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer PatientsNot yet recruitingNCT07254416Phase 4
• A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer CachexiaRecruitingNCT07243379Phase 4
• Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung CancerRecruitingNCT07150663Phase 3
• Nano-crystalline Megestrol Acetate for Anorexia-Cachexia Syndrome in Advanced Lung CancerNot yet recruitingNCT07092137Phase 2
• Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRCRecruitingNCT06998758Phase 3
• A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)RecruitingNCT06979596Phase 2
• Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia PhaseNot yet recruitingNCT06961201Phase 3
• Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology AnalysisNot yet recruitingNCT06961188Phase 3
• Nanocrystalline Megestrol Acetate for the Treatment of Anorexia-Cachexia Syndrome in Extensive-Stage Small Cell Lung Cancer: A Prospective, Open-Label, Single-Arm Phase II Clinical StudyNot yet recruitingNCT06909383Phase 2
• Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related FatigueRecruitingNCT06830018Not applicable
• Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma After Surgery.Not yet recruitingNCT06772428Phase 3
• Nutrition Impact on Immunotherapy of CancerRecruitingNCT06500234Phase 3
• Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age WomenRecruitingNCT06417736Not applicable
• Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)RecruitingNCT05913427Phase 2
• Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical HyperplasiaRecruitingNCT05316493Phase 2/3
• iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in ChildrenCompletedNCT03815019Phase 4Results posted
• Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial AdenocarcinomaCompletedNCT01968317Phase 2Results posted
• Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or ChemotherapyTerminatedNCT01200602Phase 2Results posted
• Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial CancerCompletedNCT00729586Phase 2Results posted
• Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated SuspensionTerminatedNCT00637806Phase 3Results posted
• Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer PatientsTerminatedNCT00637728Phase 3Results posted
• Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight LossCompletedNCT00637572Phase 2Results posted
• A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine CancerCompletedNCT00584857Phase 2Results posted
• Adrenal Suppression and Adrenal Recovery Induced by Megestrol AcetateCompletedNCT00575029Not applicableResults posted
• Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial HyperplasiaTerminatedNCT00503581Phase 2Results posted
• Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol AcetateCompletedNCT00483327Phase 2Results posted
• A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in SingaporeStatus unknownNCT05492487Phase 2
• Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial CancerTerminatedNCT05332483Phase 1
• Weight Management Plus Megestrol Acetate in Early-stage Endometrioid CarcinomaTerminatedNCT05316467Phase 2/3
• Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial HyperplasiaTerminatedNCT04607252Phase 2/3
• Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial HyperplasiaCompletedNCT04491682Phase 2/3
• Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial CarcinomaCompletedNCT04491643Phase 2
• Clinical Trial of Rapid Progressive Central Precocious Puberty With Integrative Chinese and Western MedicineCompletedNCT03963752Phase 4
• The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With MegestrolStatus unknownNCT03777930Phase 4
• A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast CancerCompletedNCT03306472Phase 2
• Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical HyperplasiaCompletedNCT03241888Phase 2/3
• A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast CancerStatus unknownNCT03024580Phase 2
• Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRTStatus unknownNCT02980653Phase 2
• Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial CancerWithdrawnNCT01943058Phase 2
• A Clinical Trial to Evaluate Pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in Healthy Male Volunteers Under Fed ConditionStatus unknownNCT01383330Phase 1
• Evaluating the Effect of Food on Absorption of Megace ESCompletedNCT00638079Phase 1
• Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated SuspensionTerminatedNCT00637403Phase 1
• Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of WeightCompletedNCT00507949Phase 2
• Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia PatientsTerminatedNCT00503516Phase 2/3
• Pharmacokinetics and Safety of Transdermal Megestrol AcetateWithdrawnNCT00163072Phase 4
• Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for CancerCompletedNCT00070148Phase 3
• Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer TreatmentCompletedNCT00066248Phase 2
• Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT00041275Phase 3
• Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung CancerCompletedNCT00031785Phase 3
• Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of AppetiteCompletedNCT00031707Phase 3
• Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial CancerTerminatedNCT00016341Phase 3
• Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck CancerCompletedNCT00006799Phase 3
• S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast CancerCompletedNCT00005975Phase 3
• Megestrol and Exercise in Treating Patients With Cancer-Related Weight LossCompletedNCT00004912Phase 2
• High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or MesotheliomaStatus unknownNCT00002465Phase 1/2
• The Safety and Effectiveness of Megace in HIV-Infected WomenCompletedNCT00002345Phase 4
• A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and MalnutritionCompletedNCT00002300Phase 2
• A Study of Megestrol Acetate in HIV-Infected ChildrenCompletedNCT00002182Not applicable
• A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and CachexiaCompletedNCT00002067Phase 3
• A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight LossCompletedNCT00001079Phase 2
• A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting SyndromeCompletedNCT00000737Phase 1

← Megestrol Acetate overview